Cardiology News

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced its financial results for the quarter ended March 31, 2026. Total revenues in the first quarter of 2026 decreased by two percent year-over-year to $781.5 million, compared to $794.4 million in the first quarter of 2025. “In the first quarter of 2026, we extended our run of clinical success, with positive results from both our ADVANCE O...

LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the first quarter ended March 31, 2026 and raised full-year 2026 guidance. Financial Summary and Highlights(1) First-quarter revenue of $362.3 million increased 14.3% on a reported basis and 11.1% on a constant-currency basis as compared to the prior-year period First-quarter U.S. GAAP diluted earnings per share of $0.40 and adjusted diluted earnings per share of $0.98 F...

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced first quarter 2026 financial results. “Our first quarter results reflect the durability of AtriCure’s growth model, fueled by disciplined execution and increased adoption of our innovative products,” said Michael Carrel, President and Chief Executive Officer...

FONTANA, Wis. & MIAMI--(BUSINESS WIRE)--The Global Initiative for Asthma (GINA) collaborates with OpenEvidence to make GINA’s evidence-based asthma strategy reports, clinical recommendations, and educational resources available directly through OpenEvidence. Under the agreement, OpenEvidence becomes a key content partner for GINA, driving the digital dissemination of asthma standards to clinicians across OpenEvidence’s rapidly expanding international footprint. Asthma affects more than 300 mill...

BOSTON & HENDERSON, Nev.--(BUSINESS WIRE)--CareQuest Innovation Partners and PDS Health Collaborate to Scale Blood Pressure Screening in Dental Offices to Advance Integrated Care...

MANHASSET, N.Y.--(BUSINESS WIRE)--World-renowned expert in thrombosis and blood clotting, Alex C. Spyropoulos, MD, Professor at the Institute of Health System Science at the Feinstein Institutes for Medical Research and Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, has been selected for a prestigious Fulbright United States Scholar award for the 2026-2027 academic year from the U.S. Department of State and the Fulbright Foreign Scholarship Board...

FOSTER CITY, Calif.--(BUSINESS WIRE)--GLP-1 medicines are being prescribed for weight loss at a scale the healthcare system has never managed before. Clinicians can measure weight loss. What they still cannot see, in any scalable, non-invasive way, is which patients are biologically positioned to respond before treatment begins, or how therapy is changing disease biology once it starts. Hepta today announced data at Digestive Disease Week 2026 showing that a blood-based assay analyzing cell-fre...

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced an exclusive worldwide license agreement with Madrigal Pharmaceuticals (NASDAQ: MDGL) for ARO-PNPLA3, Arrowhead’s clinical stage RNA interference (RNAi) therapeutic designed to reduce liver expression of patatin-like phospholipase domain containing 3 (PNPLA3) as a potential treatment for patients with metabolic dysfunction-associated steatohepatitis (MASH). “The early clinical data for ARO-PNPLA3 h...

NEW YORK--(BUSINESS WIRE)--RYALTRIS® nasal spray for seasonal allergic rhinitis is now available through BlinkRx. Transfer your Rx or visit blinkrx.com to learn more....

LOS ANGELES--(BUSINESS WIRE)--EarlyDiagnostics (EarlyDx) announced PNAS validation of its MethylScan™ platform for multi-disease detection from a single blood sample....